A recent Keystone meeting highlighted the progress in generating effective anti-cancer antibodies by manipulating antibody binding affinity and their ability to support ADCC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Keystone Symposium: Antibody-based Therapeutics for Cancer, Hilton Hotel, Santa Fe, New Mexico, February 17–22, 2005.
Schier, R. et al. J. Mol. Biol. 263, 551–567 (1996).
Colby, D.W. et al. Methods Enzymol. 388, 348–358 (2004).
Weaver-Feldhaus, J.M. FEBS Lett. 564, 24–34 (2004).
Weinstein, J.N. et al. Ann. NY Acad. Sci. 507, 199–210 (1987).
Adams G.P. et al. Cancer Res. 61, 4750–4755 (2001).
Graff, C.P. et al. Protein Eng. Des. Sel. 17, 293–304 (2004).
Cartron, G. et al. Blood 99, 754–758 (2002).
Weng, W.K. & Levy, R. J. Clin. Oncol. 21, 3940–3947 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weiner, L., Carter, P. Tunable antibodies. Nat Biotechnol 23, 556–557 (2005). https://doi.org/10.1038/nbt0505-556
Issue Date:
DOI: https://doi.org/10.1038/nbt0505-556
This article is cited by
-
Phénomène d’ADCC, polymorphismes du récepteur Fcγ et conséquences en termes de développement thérapeutique ciblé
Oncologie (2014)
-
Monoclonal antibody to six transmembrane epithelial antigen of prostate-4 influences insulin sensitivity by attenuating phosphorylation of P13K (P85) and Akt: Possible mitochondrial mechanism
Journal of Bioenergetics and Biomembranes (2011)
-
Making antibodies from scratch
Nature Biotechnology (2010)
-
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance
Cell Death & Differentiation (2008)
-
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Nature Biotechnology (2006)